EquitiesHealthcare & Biotech 20 December 2023 Neuren Pharmaceuticals (NEU): It Keeps Getting Better NEU released impressive efficacy and safety results from the first of four single-arm Phase 2 trials evaluating NNZ-2591 (n=18). BellPotter Marketing Love0
